Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Northwest Bancshares Inc is a banks-regional business based in the US. Northwest Bancshares shares (NWBI) are listed on the NASDAQ and all prices are listed in US Dollars. Northwest Bancshares employs 2,393 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$14.02|
|52-week range||$9.59 - $15.03|
|50-day moving average||$13.28|
|200-day moving average||$13.63|
|Wall St. target price||$13.40|
|Dividend yield||$0.77 (5.51%)|
|Earnings per share (TTM)||$1.28|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-21)||0.29%|
|1 month (2021-09-28)||5.89%|
|3 months (2021-07-28)||5.89%|
|6 months (2021-04-28)||-0.99%|
|1 year (2020-10-28)||34.55%|
|2 years (2019-10-28)||-18.49%|
|3 years (2018-10-26)||15.93|
|5 years (2016-10-28)||15.51|
Valuing Northwest Bancshares stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Northwest Bancshares's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Northwest Bancshares's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 11x. In other words, Northwest Bancshares shares trade at around 11x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Northwest Bancshares's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.87. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Northwest Bancshares's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
|Revenue TTM||$559.1 million|
|Operating margin TTM||40.92%|
|Gross profit TTM||$440 million|
|Return on assets TTM||1.15%|
|Return on equity TTM||10.45%|
|Market capitalisation||$1.8 billion|
TTM: trailing 12 months
There are currently 3.6 million Northwest Bancshares shares held short by investors – that's known as Northwest Bancshares's "short interest". This figure is 4.4% down from 3.7 million last month.
There are a few different ways that this level of interest in shorting Northwest Bancshares shares can be evaluated.
Northwest Bancshares's "short interest ratio" (SIR) is the quantity of Northwest Bancshares shares currently shorted divided by the average quantity of Northwest Bancshares shares traded daily (recently around 652378.24497258). Northwest Bancshares's SIR currently stands at 5.47. In other words for every 100,000 Northwest Bancshares shares traded daily on the market, roughly 5470 shares are currently held short.
However Northwest Bancshares's short interest can also be evaluated against the total number of Northwest Bancshares shares, or, against the total number of tradable Northwest Bancshares shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Northwest Bancshares's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Northwest Bancshares shares in existence, roughly 30 shares are currently held short) or 0.0414% of the tradable shares (for every 100,000 tradable Northwest Bancshares shares, roughly 41 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Northwest Bancshares.
Find out more about how you can short Northwest Bancshares stock.
Dividend payout ratio: 66.8% of net profits
Recently Northwest Bancshares has paid out, on average, around 66.8% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 5.68% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Northwest Bancshares shareholders could enjoy a 5.68% return on their shares, in the form of dividend payments. In Northwest Bancshares's case, that would currently equate to about $0.77 per share.
Northwest Bancshares's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Northwest Bancshares's most recent dividend payout was on 15 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 3 August 2021 (the "ex-dividend date").
Northwest Bancshares's shares were split on a 225:100 basis on 17 December 2009. So if you had owned 100 shares the day before before the split, the next day you'd have owned 225 shares. This wouldn't directly have changed the overall worth of your Northwest Bancshares shares – just the quantity. However, indirectly, the new 55.6% lower share price could have impacted the market appetite for Northwest Bancshares shares which in turn could have impacted Northwest Bancshares's share price.
Over the last 12 months, Northwest Bancshares's shares have ranged in value from as little as $9.5865 up to $15.0322. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Northwest Bancshares's is 0.5899. This would suggest that Northwest Bancshares's shares are less volatile than average (for this exchange).
Northwest Bancshares, Inc. operates as the holding company for Northwest Bank that provides personal and business banking solutions. The company accepts various deposits, including checking, savings, money market deposit, term certificate, and individual retirement accounts. It also offers loan products comprising residential mortgage, home equity, other consumer, commercial real estate, and commercial loans. The company also offers investment management and trust services. As of June 30, 2021, it operated 162 full-service community banking offices and 8 free standing drive-through facilities in Pennsylvania, New York, Ohio, and Indiana. The company was founded in 1896 and is headquartered in Warren, Pennsylvania.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.